This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Shandong Xinchuang Biological Technology Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jun Xing - Innovator in Tumor Marker Research
Introduction
Jun Xing is an inventor based in Jinan, China. He is associated with Shandong Xinchuang Biological Technology Co., Ltd. His work primarily focuses on the development of antigens and antibodies for use as tumor markers. Although he currently holds no granted patents, his contributions to the field are noteworthy.
Latest Patent Applications
Jun Xing's latest patent application is titled "Antigen and Antibodies Prepared Based on PADI4 Serving as Tumor Marker, and Application Thereof." This application discloses an antigen with an amino acid sequence shown as SEQ ID NO. 1, which is based on peptidylarginine deiminase (PADI4). The application also details specific antibodies prepared using this antigen. The protein PADI4 monoclonal antibodies include a protein PADI4 monoclonal antibody coated onto an ELISA plate and a biotin-labeled protein PADI4 monoclonal antibody. A kit prepared using these antibodies can effectively and stably determine the protein PADI4 level in human serum, demonstrating broad spectrum, detectability, and high test repeatability.
Conclusion
Jun Xing is making significant strides in the field of tumor marker research, with promising applications that could enhance diagnostic capabilities. His innovative work in developing specific antibodies and antigens showcases his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile